Recombinant botulinum toxin type A for injection (YY001)

BIOLOGICAL2 trials

Sponsors

Chongqing Claruvis Pharmaceutical Co., Ltd.

Conditions

Upper Limb Spasticity

Phase 2

A Clinical Study on Recombinant Botulinum Toxin Type A (YY001) for Injection in The Treatment of Upper Limb Spasticity in Adults

RecruitingNCT06783114

Chongqing Claruvis Pharmaceutical Co., Ltd.Upper Limb Spasticity

Start: 2024-09-14End: 2026-09-30Target: 254Updated: 2026-01-22

Phase 3

A Study on Recombinant Botulinum Toxin Type A (YY001) for Injection in Multiple Treatments of Adult Upper Limb Spasticity

RecruitingNCT07478822

Chongqing Claruvis Pharmaceutical Co., Ltd.Upper Limb Spasticity

Start: 2026-03-27End: 2027-06-01Target: 300Updated: 2026-04-02